These blocking mAbs inhibit growth and metastasis of human PTHrP‐positive breast and prostate cancer(42, 43, 44) and are strong inhibitors of TNBC cell growth in vitro, where they potentiate the effect of doxorubicin and taxol.(45). This evidence concerns the gene PTHLH and Familial prostate cancer.